& Biostatistics


In addition to Avalon’s core strengths in data science, statistical analysis, modelling, and data-driven analytics, the Avalon team has extensive expertise and experience in epidemiology and biostatistics. In our work in life sciences consulting, we have developed innovative approaches to the analysis of data on clinical processes, outcomes, and costs. In the development of economic models for life sciences, we have developed unique approaches beyond simple models, making use of all the value attributes of a novel drug, device, or diagnostic. We bring these same advanced statistical tools into our work in law and economics and litigation.

Types Of Engagements

  • Calculation of survival, mortality, and life expectancy in personal injury cases
  • Survival analysis in outcomes research
  • Analysis of attributable fraction & attributable risk
  • Mendelian randomization to assess causative factors in obesity
  • Statistical analysis to determine causative factors & liability
  • Estimation of market size for medical devices, diagnostics, & pharmaceuticals
  • Novel analysis of real-world data (RWD) to support value propositions & HTA submissions
  • Systematic & comprehensive summaries of literature & evidence

Key Staff

  • John Schneider, PhD
  • Andrew Briggs, DPhil, MSc
  • Anthony LoSasso, PhD
  • Robert Ohsfeldt, PhD
  • Jacie Cooper, MS

Related Markets & Industries

  • Insurance & Third-Party Payers
  • Attorneys & Law Firms
  • Medical Services
  • Hospitals & Health Systems
  • Pharmaceuticals & Biotechnology
  • Medical Devices & Diagnostics
  • Private Equity & Venture Capital
  • Consumer Products
  • Public Health
  • Government

Related Publications